We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IBTX
1726
DELISTED
Independent Bank Group, Inc.
IBTX
| $6.55M | ﹤0.01% |
109,015
-18,403
| -14% | -$1.17M |
|
|
RAPT
1727
DELISTED
RAPT Therapeutics
RAPT
| $6.55M | ﹤0.01% |
41,341
+4,580
| +12% | +$733K |
|
1728
Golar LNG
GLNG
$5.13B
| $6.52M | ﹤0.01% |
285,927
-148,523
| -34% | -$3.72M |
|
1729
Archrock
AROC
$5.8B
| $6.51M | ﹤0.01% |
725,360
-307,347
| -30% | -$2.46M |
|
1730
Kemper
KMPR
$1.68B
| $6.49M | ﹤0.01% |
131,853
-25,937
| -16% | -$1.3M |
|
1731
AMC Entertainment Holdings
AMC
$2.31B
| $6.45M | ﹤0.01% |
158,420
-40,742
| -20% | -$2.57M |
|
1732
Applovin
APP
$116B
| $6.45M | ﹤0.01% |
612,195
-8,577
| -1% | -$126K |
|
1733
Pacira BioSciences
PCRX
$997M
| $6.45M | ﹤0.01% |
166,980
-228,370
| -58% | -$11.1M |
|
1734
Nuveen ESG Large-Cap ETF
NULC
$72.8M
| $6.44M | ﹤0.01% |
200,000
-193,850
| -49% | -$6.33M |
|
1735
Snap
SNAP
$9.01B
| $6.44M | ﹤0.01% |
719,726
+44,293
| +7% | +$437K |
|
1736
Unitil
UTL
$980M
| $6.44M | ﹤0.01% |
125,370
-17,067
| -12% | -$868K |
|
1737
News Corp Class B
NWS
$17.5B
| $6.42M | ﹤0.01% |
347,988
-58,917
| -14% | -$1.04M |
|
1738
QCR Holdings
QCRH
$1.7B
| $6.41M | ﹤0.01% |
129,054
-12,829
| -9% | -$661K |
|
1739
Conduent
CNDT
$264M
| $6.4M | ﹤0.01% |
1,581,053
-377,948
| -19% | -$1.45M |
|
1740
Quaker Houghton
KWR
$2.92B
| $6.4M | ﹤0.01% |
38,322
-3,464
| -8% | -$583K |
|
|
IMGN
1741
DELISTED
Immunogen Inc
IMGN
| $6.39M | ﹤0.01% |
1,288,180
+634,141
| +97% | +$3.44M |
|
|
CPE
1742
DELISTED
Callon Petroleum Company
CPE
| $6.38M | ﹤0.01% |
172,132
-19,332
| -10% | -$794K |
|
1743
Genesco
GCO
$422M
| $6.38M | ﹤0.01% |
138,594
-101,944
| -42% | -$4.63M |
|
1744
Green Dot
GDOT
$745M
| $6.38M | ﹤0.01% |
403,272
-72,492
| -15% | -$1.34M |
|
1745
A10 Networks
ATEN
$1.95B
| $6.38M | ﹤0.01% |
383,356
+171,815
| +81% | +$2.94M |
|
1746
Goosehead Insurance
GSHD
$2.32B
| $6.36M | ﹤0.01% |
185,152
+131,451
| +245% | +$4.92M |
|
|
ESPR
1747
DELISTED
Esperion Therapeutics
ESPR
| $6.35M | ﹤0.01% |
1,019,196
+717,837
| +238% | +$5.13M |
|
1748
Kaiser Aluminum
KALU
$3.02B
| $6.33M | ﹤0.01% |
83,329
-20,134
| -19% | -$1.61M |
|
|
VTYX
1749
DELISTED
Ventyx Biosciences
VTYX
| $6.33M | ﹤0.01% |
192,933
+123,882
| +179% | +$3.67M |
|
|
AMED
1750
DELISTED
Amedisys
AMED
| $6.28M | ﹤0.01% |
75,183
-2,357
| -3% | -$213K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.